BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 28592434)

  • 1. Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking Rosuvastatin Open Label).
    Braamskamp MJAM; Langslet G; McCrindle BW; Cassiman D; Francis GA; Gagne C; Gaudet D; Morrison KM; Wiegman A; Turner T; Miller E; Kusters DM; Raichlen JS; Martin PD; Stein EA; Kastelein JJP; Hutten BA
    Circulation; 2017 Jul; 136(4):359-366. PubMed ID: 28592434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of rosuvastatin therapy in children and adolescents with familial hypercholesterolemia: Results from the CHARON study.
    Braamskamp MJAM; Langslet G; McCrindle BW; Cassiman D; Francis GA; Gagné C; Gaudet D; Morrison KM; Wiegman A; Turner T; Kusters DM; Miller E; Raichlen JS; Wissmar J; Martin PD; Stein EA; Kastelein JJP
    J Clin Lipidol; 2015; 9(6):741-750. PubMed ID: 26687694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and baseline data of a pediatric study with rosuvastatin in familial hypercholesterolemia.
    Kusters DM; Hutten BA; McCrindle BW; Cassiman D; Francis GA; Gagné C; Gaudet D; Morrison KM; Langslet G; Kastelein JJ; Wiegman A
    J Clin Lipidol; 2013; 7(5):408-13. PubMed ID: 24079281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carotid intima-media thickness in children with familial hypercholesterolemia.
    Kusters DM; Wiegman A; Kastelein JJ; Hutten BA
    Circ Res; 2014 Jan; 114(2):307-10. PubMed ID: 24192652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
    Kastelein JJ; Akdim F; Stroes ES; Zwinderman AH; Bots ML; Stalenhoef AF; Visseren FL; Sijbrands EJ; Trip MD; Stein EA; Gaudet D; Duivenvoorden R; Veltri EP; Marais AD; de Groot E;
    N Engl J Med; 2008 Apr; 358(14):1431-43. PubMed ID: 18376000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Letter by Koh Regarding Article, "Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking Rosuvastatin Open Label)".
    Koh KK
    Circulation; 2018 Feb; 137(6):639-640. PubMed ID: 29431666
    [No Abstract]   [Full Text] [Related]  

  • 7. Response by Kusters et al to Letter Regarding Article, "Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking Rosuvastatin Open Label)".
    Kusters DM; Braamskamp MJAM; Langslet G; McCrindle BW; Cassiman D; Francis GA; Gagne C; Gaudet D; Morrison KM; Wiegman A; Turner T; Miller E; Raichlen J; Martin PD; Stein EA; Kastelein JJP; Hutten BA
    Circulation; 2018 Feb; 137(6):641-642. PubMed ID: 29431667
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevalence of heterozygous familial hypercholesterolemia and combined hyperlipidemia phenotype in very young survivors of myocardial infarction and their association with the severity of atheromatous burden.
    Rallidis LS; Kosmas N; Tsirebolos G; Rallidi M; Kiouri E; Kalpakos D
    J Clin Lipidol; 2019; 13(3):502-508. PubMed ID: 30956097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 20-Year Follow-up of Statins in Children with Familial Hypercholesterolemia.
    Luirink IK; Wiegman A; Kusters DM; Hof MH; Groothoff JW; de Groot E; Kastelein JJP; Hutten BA
    N Engl J Med; 2019 Oct; 381(16):1547-1556. PubMed ID: 31618540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein B synthesis inhibition with mipomersen in heterozygous familial hypercholesterolemia: results of a randomized, double-blind, placebo-controlled trial to assess efficacy and safety as add-on therapy in patients with coronary artery disease.
    Stein EA; Dufour R; Gagne C; Gaudet D; East C; Donovan JM; Chin W; Tribble DL; McGowan M
    Circulation; 2012 Nov; 126(19):2283-92. PubMed ID: 23060426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial.
    Crouse JR; Raichlen JS; Riley WA; Evans GW; Palmer MK; O'Leary DH; Grobbee DE; Bots ML;
    JAMA; 2007 Mar; 297(12):1344-53. PubMed ID: 17384434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rosuvastatin slows progression of subclinical atherosclerosis in patients with treated HIV infection.
    Longenecker CT; Sattar A; Gilkeson R; McComsey GA
    AIDS; 2016 Sep; 30(14):2195-203. PubMed ID: 27203715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia.
    Kastelein JJ; van Leuven SI; Burgess L; Evans GW; Kuivenhoven JA; Barter PJ; Revkin JH; Grobbee DE; Riley WA; Shear CL; Duggan WT; Bots ML;
    N Engl J Med; 2007 Apr; 356(16):1620-30. PubMed ID: 17387131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intima-media thickness after cholesterol lowering in familial hypercholesterolemia. A three-year ultrasound study of common carotid and femoral arteries.
    Wendelhag I; Wiklund O; Wikstrand J
    Atherosclerosis; 1995 Oct; 117(2):225-36. PubMed ID: 8801868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carotid artery plaques and intima medial thickness in familial hypercholesteraemic patients on long-term statin therapy: A case control study.
    Bos S; Duvekot MH; Ten Kate GR; Verhoeven AJ; Mulder MT; Schinkel AF; Nieman K; Watts GF; Sijbrands EJ; Roeters van Lennep JE
    Atherosclerosis; 2017 Jan; 256():62-66. PubMed ID: 28012444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of ezetimibe plus simvastatin versus simvastatin monotherapy on atherosclerosis progression in familial hypercholesterolemia. Design and rationale of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression (ENHANCE) trial.
    Kastelein JJ; Sager PT; de Groot E; Veltri E
    Am Heart J; 2005 Feb; 149(2):234-9. PubMed ID: 15846260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial dysfunction, but not structural atherosclerosis, is evident early in children with heterozygous familial hypercholesterolemia.
    Vlahos AP; Naka KK; Bechlioulis A; Theoharis P; Vakalis K; Moutzouri E; Miltiadous G; Michalis LK; Siamopoulou-Mavridou A; Elisaf M; Milionis HJ
    Pediatr Cardiol; 2014 Jan; 35(1):63-70. PubMed ID: 23821294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors Associated with Carotid Atherosclerosis and Achilles Tendon Thickness in Japanese Patients with Familial Hypercholesterolemia: A Subanalysis of the Familial Hypercholesterolemia Expert Forum (FAME) Study.
    Ogura M; Harada-Shiba M; Masuda D; Arai H; Bujo H; Ishibashi S; Daida H; Koga N; Oikawa S; Yamashita S
    J Atheroscler Thromb; 2022 Jun; 29(6):906-922. PubMed ID: 34108342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of intensive lipid-lowering therapy with rosuvastatin on progression of carotid intima-media thickness in Japanese patients: Justification for Atherosclerosis Regression Treatment (JART) study.
    Nohara R; Daida H; Hata M; Kaku K; Kawamori R; Kishimoto J; Kurabayashi M; Masuda I; Sakuma I; Yamazaki T; Yokoi H; Yoshida M;
    Circ J; 2012; 76(1):221-9. PubMed ID: 22094911
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.